High Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) Analysis of GBS Glycoconjugate Vaccines: From Fermentation to Final Product

Applications of Ion Chromatography for Pharmaceutical and Biological Products

Volumn , Issue , 2012, Pages 423-434

  Ricci, Stefano ^a   Fabbri, Barbara ^a   Giannini, Sara ^a   Bernardini, Silvia ^a   Morelli, Marcello ^a   D'Ascenzi, Sandro ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Fermentation to final product; Free NeupNAc, stability parameter; HPAEC, GBS glycoconjugate vaccines

Indexed keywords

EID: 84885964448     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118147009.ch23     Document Type: Chapter

References (9)

1. Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. Journal of Pediatrics 1993;122(4):638-640.
2. Farley MM. Group B streptococcal disease in nonpregnant adults. Clinical Infectious Diseases 2001;33:556-561.
3. Von Hunolstein C, D'Ascenzi S, Wagner B, Jelinkova J, Alfarone G, Recchia S, Wagner M, Orefici G. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (Group B Streptococci). Infection and Immunity 1993;61(4):1272-1280.
4. Ricci S, Bardotti A, D'Ascenzi S, Ravenscroft N. Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection. Vaccine 2001;19:1989-1997.
5. Bardotti A, Averani G, Berti F, Berti S, Galli C, Giannini S, Fabbri B, Proietti D, Ravenscroft N, Ricci S. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135. Vaccine 2005;23:1887-1899.
6. D'Ascenzi S, von Hunolstein C, Dentini M, Alfarone G, Crescenzi V, Orefici G. Characterization of group B streptococcus type capsular polysaccharide. New perspective on streptococci and streptococcal infections, XI Lancefield International Symposium, Siena, September 10-14, 1990, pp. 458-460.
7. Deng L, Kasper DL, Krick TP, Wessels MR. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J. Biol. Chem. 2000;275:7497-7504.
8. Bardotti A, Ravenscroft N, Ricci S, D'Ascenzi S, Guarnieri V, Averani G, Costantino P. Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection. Vaccine 2000;18(19):1982-1993.
9. Bardotti A, Averani G, Berti F, Berti S, Carinci V, D'Ascenzi S, Fabbri B, Giannini S, Giannozzi A, Magagnoli C, Proietti D, Norelli F, Rappuoli R, Ricci S, Costantino P. Physicochemical characterization of glycoconjugate vaccines for prevention of meningococcal diseases. Vaccine 2008;26(18):2284-2296.